Clinical monitoring is a fundamental component of diabetes care and is essential for evaluating glycaemic control, assessing treatment effectiveness, detecting complications at an early stage, and reducing long-term morbidity and mortality. Diabetes is a lifelong disease that requires regular follow-up to monitor metabolic control and identify complications involving the cardiovascular system, kidneys, eyes, peripheral nerves, and feet.

Monitoring should be individualized according to the type of diabetes, duration of disease, treatment regimen, presence of complications, and associated comorbidities. A structured follow-up schedule enables timely adjustment of therapy, reinforces patient education, and improves overall clinical outcomes.

Objectives of clinical monitoring

The objectives of follow-up are to:

• Assess glycaemic control

• Evaluate adherence to treatment

• Detect diabetes-related complications early

• Monitor medication safety

• Identify cardiovascular risk factors

• Reinforce lifestyle modification

• Provide continuous patient education

• Optimize long-term treatment outcomes

Initial assessment

Every newly diagnosed patient should undergo a comprehensive baseline evaluation.

Clinical history

The history should include:

• Duration and onset of symptoms

• Polyuria, polydipsia, polyphagia, and weight loss

• Previous episodes of hyperglycaemia or hypoglycaemia

• Current medications

• Previous diabetes treatment

• Family history of diabetes

• Cardiovascular disease

• Hypertension

• Dyslipidaemia

• Smoking history

• Alcohol intake

• Physical activity

• Dietary habits

• Previous pregnancies and gestational diabetes (where applicable)

• History of diabetic complications

Physical examination

A complete physical examination should include:

General assessment

• Height

• Weight

• Body mass index (BMI)

• Waist circumference

• Hip circumference

Vital signs

• Blood pressure

• Pulse rate

Cardiovascular examination

Assess for:

• Peripheral pulses

• Signs of heart failure

• Peripheral vascular disease

Foot examination

Evaluate for:

• Ulcers

• Skin integrity

• Foot deformities

• Peripheral pulses

• Peripheral neuropathy

• Infection

• Callus formation

• Footwear assessment

Eye assessment

• Visual acuity

• Fundoscopy or retinal examination

Oral examination

Assess for:

• Dental disease

• Periodontal disease

• Oral infections

Baseline laboratory investigations

The following investigations should be performed at diagnosis:

Glycaemic assessment

• Fasting plasma glucose

• Random blood glucose

• HbA1c

Renal assessment

• Serum creatinine

• Estimated glomerular filtration rate (eGFR)

• Urinalysis

• Urine albumin

• Urine albumin-to-creatinine ratio (UACR) where available

Lipid profile

• Total cholesterol

• LDL cholesterol

• HDL cholesterol

• Triglycerides

Additional investigations

Where clinically indicated:

• Liver function tests

• Electrolytes

• Electrocardiogram (ECG)

• Full blood count

Patient education at diagnosis

Every newly diagnosed patient should receive education regarding:

• Nature of diabetes

• Lifestyle modification

• Dietary management

• Physical activity

• Medication adherence

• Recognition of hypoglycaemia

• Recognition of hyperglycaemia

• Foot care

• Self-monitoring of blood glucose

• Smoking cessation

• Alcohol moderation

• Importance of regular follow-up

Three-month follow-up

Patients should generally be reviewed every three months until glycaemic control is stable.

Clinical assessment

Assess:

• Symptoms

• Weight

• Blood pressure

• Medication adherence

• Lifestyle adherence

• Episodes of hypoglycaemia

• Episodes of hyperglycaemia

Foot examination

Inspect for:

• Ulcers

• Infection

• Skin changes

• Loss of sensation

• Peripheral pulses

Laboratory investigations

Review:

• Blood glucose

• HbA1c (every three months until stable)

• Urine protein when indicated

Treatment review

Evaluate:

• Achievement of glycaemic targets

• Medication tolerance

• Adverse effects

• Need for dose adjustment

• Need for treatment intensification

Lifestyle counselling should be reinforced at every visit.

Annual comprehensive review

A detailed assessment should be performed at least once every year.

Medical history

Review:

• Glycaemic control

• Hospital admissions

• Cardiovascular events

• Hypoglycaemia

• Medication changes

• Smoking

• Alcohol intake

• Physical activity

Physical examination

Repeat:

• Weight

• BMI

• Waist circumference

• Blood pressure

• Cardiovascular examination

• Comprehensive foot examination

• Eye examination

• Dental assessment

Laboratory investigations

Repeat:

• HbA1c

• Lipid profile

• Serum creatinine

• eGFR

• Urinalysis

• Urine albumin or UACR

Additional investigations should be requested when clinically indicated.

Monitoring for chronic complications

Regular surveillance should focus on the early detection of diabetes-related complications.

Diabetic retinopathy

Screen with:

• Dilated retinal examination or retinal photography

Patients with established retinopathy require ophthalmology referral and follow-up.

Diabetic kidney disease

Monitor:

• Serum creatinine

• eGFR

• Urine albumin

• UACR

Patients with persistent albuminuria or declining renal function require further evaluation and management.

Diabetic neuropathy

Assess for:

• Loss of protective sensation

• Painful neuropathy

• Autonomic symptoms

• Foot ulcer risk

Diabetic foot disease

Evaluate for:

• Peripheral arterial disease

• Foot deformities

• Ulceration

• Infection

• Charcot arthropathy

Patients at high risk should receive regular podiatric assessment and preventive foot care.

Cardiovascular disease

Monitor cardiovascular risk factors including:

• Blood pressure

• Lipid profile

• Smoking status

• Body weight

• Physical activity

Appropriate management of hypertension and dyslipidaemia should accompany glycaemic control.

Monitoring treatment effectiveness

Treatment effectiveness should be assessed by reviewing:

• HbA1c

• Fasting blood glucose

• Postprandial glucose when appropriate

• Frequency of hypoglycaemia

• Medication adherence

• Weight changes

• Blood pressure

• Quality of life

Failure to achieve treatment goals should prompt reassessment of adherence, lifestyle measures, medication regimen, and possible treatment intensification.

Recommended monitoring schedule

Special situations requiring more frequent monitoring

Patients should be reviewed more frequently if they have:

• Pregnancy

• Newly diagnosed diabetes

• Poor glycaemic control

• Recent insulin initiation

• Recurrent hypoglycaemia

• Advanced chronic kidney disease

• Acute illness

• Hospitalization

• Active diabetic foot disease

• Rapid progression of diabetic complications

Patient education during follow-up

Education should be reinforced at every clinic visit and should include:

• Medication adherence

• Healthy eating

• Weight management

• Regular physical activity

• Foot care

• Home blood glucose monitoring where appropriate

• Recognition of hypo- and hyperglycaemia

• Smoking cessation

• Alcohol moderation

• Importance of routine screening for complications

Clinical pearls

• Clinical monitoring is a lifelong process and should continue even when glycaemic control is stable.

• HbA1c should be measured every three months until treatment goals are achieved and at least every six months thereafter in stable patients.

• Comprehensive foot examination and blood pressure measurement should be performed regularly to reduce the risk of preventable complications.

• Annual screening for retinopathy, kidney disease, and cardiovascular risk factors is essential for all adults with diabetes.

• Regular patient education, lifestyle counselling, and medication review are integral components of every follow-up visit.